SKIN DISEASE DRUG

AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study

​Rinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent, the study showed.